SCHEMBL7401374

SCHEMBL7401374

N#Cc1ccc(N2CCN(CCC3CCc4ccccc43)CC2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.48
DRD4 P21917 4/20 0.48
HTR1A P08908 2/20 0.48
HTR2A P28223 2/20 0.48
ADRA1D P25100 2/20 0.48
ADRA1A P35348 2/20 0.48
ADRA1B P35368 2/20 0.48
DRD1 P21728 2/20 0.48
DRD3 P35462 2/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA2C P18825 1/20 0.48
HTR2B P41595 1/20 0.48
HTR1D P28221 1/20 0.46
CCR5 P51681 1/20 0.46
HTR7 P34969 2/20 0.45
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7405539 0.84 ALDH1A1 (0.53) DRD2DRD4HTR1AHTR2AADRA1D
Hydrochloric Acid SCHEMBL8185523 0.83 ALDH1A1 (0.52) DRD2DRD4HTR1AHTR2AADRA1D
SCHEMBL7397854 0.81 DRD4 (0.68) DRD2DRD4HTR1AHTR2AADRA1A
SCHEMBL10407922 0.81 KCNH2 (0.48) DRD2DRD4HTR1AHTR2AADRA1D
SCHEMBL7402811 0.81 DRD2 (0.46) DRD2DRD4HTR1AHTR2AADRA1D
Hydrochloric Acid SCHEMBL8185604 0.81 DRD4 (0.67) DRD2DRD4HTR1AHTR2AHTR1D
SCHEMBL7403486 0.80 DRD2 (0.50) DRD2DRD4HTR1AHTR2AADRA1D
SCHEMBL27524409 0.80 DRD2 (0.69) DRD2DRD4HTR1AHTR2AADRA1D
SCHEMBL9052228 0.78 DRD2 (0.47) DRD2DRD4HTR1AHTR2AADRA1D
SCHEMBL7403278 0.78 ALDH1A1 (0.59) DRD2DRD4HTR1AHTR2AADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1139431-A Heterocyclic compounds for the treatment of central nervous system and cardiovascular diseases PHARMACIA & UPJOHN CO LLC (US) 1997-01-01 CN claimed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP claimed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO claimed
US-6133446-A Heterocyclic compounds for the treatment of CNS and cardiovascular disorders PHARMACIA & UPJOHN COMPANY (US) 2000-10-17 US disclosed
CN-1046507-C Heterocyclic compounds for the treatment of central nervous system and cardiovascular diseases UPJOHN CO (US) 1999-11-17 CN disclosed
CN-1139431-A Heterocyclic compounds for the treatment of central nervous system and cardiovascular diseases PHARMACIA & UPJOHN CO LLC (US) 1997-01-01 CN disclosed
EP-0737189-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS PHARMACIA & UPJOHN COMPANY (US) 1996-10-16 EP disclosed
WO-1995018118-A1 HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF CNS AND CARDIOVASCULAR DISORDERS THE UPJOHN COMPANY (US) 1995-07-06 WO disclosed